Simvastatin 20 mg

Indication : Treatment with lipid-altering agents can be considered for use in patiens which have increased atherosclerosis vascular risk that caused by hypercholesterolemia.
Treatment with lipid-altering agents is indicated as an adjunct to diet, when response to diet and other non-pharmacological measures alone has been inadequate.
Coronary Heart Disease (CHD)
In patients with heart coronary disease and hypercholesterolemia, Simvastatin is indicated to :
-Reduce the risk of total mortality by reducing CHD deaths.
-Reduce the risk of non-fatal myocardial infarction.
-Reduce the risk in patients taking myocardial revascularization procedures.
Hypercholesterolemia
Reduction of elevated total and LDL-cholesterol levels in patients with primary hypercholesterolemia (Type IIa and IIb).
For more information, see inserts.

Composition : Each Simvastatin Film coated tablet contains: Simvastatin 20 mg.

Presentation : Simvastatin Film coated tablet 20 mg
Box, 3 strips @ 10 film coated tablets

On medical prescription only.
Store below 30⁰C.
For more information, please check e-catalog